Based on the forecasted data, the import of Medicinal and Pharmaceutical Products in the Philippines is expected to continue an upward trajectory from 2024 to 2028. The value of imports is projected to grow steadily from 138.98 billion Philippine Pesos in 2024 to 158.66 billion Philippine Pesos in 2028. To understand the yearly variations, we observe that there is a consistent annual increase in import values.
Year-on-year variation percentages demonstrate this growth pattern:
- 2024 to 2025: an increase of approximately 3.65%
- 2025 to 2026: an increase of approximately 3.45%
- 2026 to 2027: an increase of approximately 3.27%
- 2027 to 2028: an increase of approximately 3.10%
Taking a broader perspective, the Compound Annual Growth Rate (CAGR) over the five-year period indicates an average annual growth rate of around 3.37%.
For future trends, several factors will be important to watch:
- Increasing demand for healthcare services due to ageing population and rise in chronic diseases.
- Government policies aimed at improving healthcare infrastructure and accessibility.
- Innovations and advancements in the pharmaceutical industry affecting import patterns.
- Economic conditions and currency fluctuations impacting import capabilities.
